Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 11, 2007

deCODE Biostructures and InterMune Expand Screening Collaboration

  • deCODE biostructures initiated a third research project with InterMune. Under the research agreement, deCODE biostructures will conduct screening of its Fragments of Life™ library against an InterMune target. The research fee and milestone-based research collaboration will utilize deCODE's proprietary Fragments of Life technology and crystallographic methods to enable identification of new chemical intellectual property for small molecule inhibitors of InterMune's drug target.


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »